Harmonised General Chapter on Chromatography
![Statistical Simulations for Enhanced Understanding of Analytical Performance - Live Webinar](files/eca/userImages/training.img/Z-ECA-Webinar-Statistical-Simulations.jpg)
Recommendation
Monday, 9 September 2024 14.00 - 16.00 h
The EDQM has announced that the harmonised general chapter Chromatography was signed-off by the Pharmacopoeial Discussion Group (PDG), which brings together the European Pharmacopoeia (Ph. Eur.), Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP).
Harmonised Requirements
In a press release dated 08 November 2021, the EDQM states that during the harmonisation of the text, particular attention was paid to the following aspects:
- Terminology, definitions and interpretation of chromatograms
- System suitability
- Adjustment of chromatographic conditions
- Quantitation procedures
The approach goes back to joint PDG–industry meeting in 2009, on which the PDG was encouraged to add harmonisation of the three regional chapters on chromatography to the PDG work programme.
The corresponding regional texts are scheduled for publication according to the following dates:
- Ph. Eur.: July 2022
- JP: December 2022
- USP: December 2022
JP Drafts for Public Comments
We recently reported that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) had published the following four Japanese Pharmacopoeia (JP) drafts of General Tests and General Information related to Chromatography:
- Draft of new General Test “<2.00> Chromatography”
- Draft of revised General Test “<2.01> Liquid Chromatography”
- Draft of revised General Test “<2.02> Gas Chromatography”
- Draft of new General Information “<G1-5-181> Control Strategies and Change Control Concepts at Each Stage of Chromatography Lifecycle” (Change Control in Lifecycle of Chromatography)
These four drafts have been under public consultation since September.
In addition, the following document was published at the beginning of November:
- Draft of revised General Information "<G1-2-181> System Suitability"
The drafts are available on the PMDA's website. Comments can be submitted until November 30, 2021.
Further information can be found in the "Briefing on drafts of General Tests and General Information related to Chromatography"
Related GMP News
24.07.2024FDA Warning Letter to Chinese OTC Manufacturer for Lack of Analytical Test Data
10.07.2024Pharmeuropa: Two Revised Chapters on Dissolution Testing published for comments
03.07.2024FDA Warning Letter: GMP Requirements also apply to HPLC Analyses for Internal Use
12.06.2024NMPA Announcement on Application of ICH Q2(R2) and Q14 Principles
22.05.2024Q&As from the Live Online Training "Introduction to the AQCG's new AIQSV Guide" - Part 1
22.05.2024FDA Warning Letter to Contract Testing Laboratory in Uruguay due to Data Integrity Violations